According to the latest data from the Hong Kong Stock Exchange, on 22 September, China Universal Asset Management Co., Ltd. increased its holdings in Kelun-Biotech (06990) by 25,200 shares at a price of HK$490.7615 per share, for a total consideration of approximately HK$12.3672 million.

Following the increase, its latest shareholding stood at 8.8446 million shares, representing a latest shareholding ratio of 5%.